Comparison of Intrathecal Bupivacaine Versus Bupivacaine plus Dexmedetomidine for Postoperative Pain Relief in Terms of Quality and Duration

Zainab Afzal; Zahid Akhtar  Rao; Syed  Sameuddin; Muhammad  Khalid; Muhsan  Sultan; Najm Us  Saqib

doi:10.51253/pafmj.v75i6.11937

Authors

Zainab Afzal Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan
Zahid Akhtar Rao Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan
Syed Sameuddin Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan
Muhammad Khalid Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan
Muhsan Sultan Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan
Najm Us Saqib Department of Anesthesia, Fazaia Ruth PFAU Medical College, Karachi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i6.11937

Keywords:

Bupivacaine, Cesarean Section, Dexmedetomidine and spinal Anaesthesia

Abstract

Objective: To measure the clinical efficacy of intrathecal Bupivacaine alone versus intrathecal Bupivacaine plus Dexmedetomidine on postoperative pain alleviation in terms of quality and duration in women undergoing C-section

Study Design: Randomized controlled trial, (Iranian Clinical Trial Registry: 76165)

Place and Duration of Study: Department of Anaesthesiology, PAF Hospital (Faisal), Karachi Pakistan from Sep, 2023 to Feb 2024.

Methodology: After registration with trial registry (ICTR) and ethical approval, this randomized controlled trial was performed in Anaesthesia department of PAF Hospital (Faisal), Karachi. Intrathecal Dexmedetomidine was given as an adjuvant to Bupivacaine in 33 gravid ladies (Group A) after randomization. Group A and Group B patients were followed for 24 hours post-operatively to assess duration and quality of analgesia. Statistical significance was compared between both study Groups.

Results: At twenty-four hours of time lapse, 2(6.1%) Group A patients had mild pain, 24(72.7%) had moderate pain and 7(21.2%) had severe pain compared to 7(21.2%) Group B patients who had moderate pain and 26(78.8%) had severe pain with p-value <0.001. The frequency of rescue analgesia was three times in 1(3.0) Group A and 10(30.3) Group B patients. The mean dose of analgesic ketorolac used by Group A patients was 53.64±23.4 milligrams with median dose of 60mg (IQR 30-120) compared to 110.91±19.099 milligrams in Group B with median dose of 120.0mg (IQR 60.0-150.0).

Conclusion: We concluded that intrathecal Dexmedetomidine provides better postoperative analgesia in terms of quality and duration when used as an adjuvant with local anesthetic Bupivacaine.

Downloads

Download data is not yet available.

References

1. Kintu A, Abdulla S, Lubikire A, Nabukenya MT, Igaga E, Bulamba F, et al. Postoperative pain after cesarean section: assessment and management in a tertiary hospital in a low-income country. BMC Health Serv Res 2019; 19(1): 1-6.

https://doi.org/10.1186/s12913-019-3911-x

2. Borges NC, de Deus JM, Guimarães RA, Conde DM, Bachion MM, de Moura LA, et al. The incidence of chronic pain following Cesarean section and associated risk factors: A cohort of women followed up for three months. PLoS One 2020; 15(9): e0238634. https://doi.org/10.1371/journal.pone.0238634

3. Veef E, Van de Velde M. Post-cesarean section analgesia. Best Pract Res Clin Anaesthesiol 2022; 36(1): 83-88.

https://doi.org/10.1016/j.bpa.2022.02.006

4. Kerai S, Saxena KN, Taneja B. Post-caesarean analgesia: What is new?. Indian J Anaesth 2017; 61(3): 200.

https://doi.org/10.4103/ija.IJA_313_16

5. Mehta N. Adjuvant drugs to local anesthetics. InTopics in Local Anesthetics 2020 May 6. Intech Open.

http://doi.org/10.5772/intechopen.91980

6. Azemati S, Zarghami A, Jouybar R, Naderi-Boldaji V. Analgesic Characteristics of Bupivacaine Alone and in Combination with Dexmedetomidine or Meperidine in Spinal Anaesthesia during Cesarean Section: A Double-Blind Randomized Clinical Trial Study. Pain Res Manag 2022; 7(14): 15-18.

https://doi.org/10.1155/2022/5111214

7. Liu X, Li Y, Kang L, Wang Q. Recent advances in the clinical value and potential of dexmedetomidine. Inflamm Res 2021; 14: 7507. https://doi.org/10.2147/JIR.S346089

8. Paramasivan A, Lopez‐Olivo MA, Foong TW, Tan YW, Yap AP. Intrathecal dexmedetomidine and postoperative pain: A systematic review and meta‐analysis of randomized controlled trials. Eur J Pain 2020; 24(7): 1215-1227.

https://doi.org/10.1002/ejp.1575

9. Gupta R, Bogra J, Verma R, Kohli M, Kushwaha JK, Kumar S et al. Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia. Indian J Anaesth 2011; 55(4): 347-51.

https://doi.org/10.4103/0019-5049.84841

10. Suzuki H, Aono S, Inoue S, Imajo Y, Nishida N, Funaba M, et al. Clinically significant changes in pain along the Pain Intensity Numerical Rating Scale in patients with chronic low back pain. PloS One 2020; 15(3): e0229228.

https://doi.org/10.1371/journal.pone.0229228

11. Karnina R, Rahayu NS, Faruk M. Factors influencing Bromage score in post-spinal Anaesthesia patients. Bali Med J 2022; 11(3): 1146-50. https://doi.org/10.15562/bmj.v11i3.3435

12. Kumar S, Choudhury B, Varikasuvu SR, Singh H, Kumar S, Lahon J, et al. A Systematic Review and Meta-analysis of Efficacy and Safety of Dexmedetomidine Combined With Intrathecal Bupivacaine Compared to Placebo. Cureus 2022; 14(12): e3245.

https://doi.org/10.7759/cureus.32425

13. Liu S, Sun Y, Wang Y. Comparison of the effect of dexmedetomidine intrathecal injection and intravenous infusion on subarachnoid blockade during knee arthroscopy procedures: a randomized controlled trial. BMC Anesthesiol 24; 16: 2401-2409. https://doi.org/10.1186/s12871-023-02401-9

14. James KS, McGrady E, Quasim I, Patrick A. Comparison of epidural bolus administration of 0.25% bupivacaine and 0.1% bupivacaine with 0.0002% fentanyl for analgesia during labour. Br J Anaesth 1998; 81(4): 507-510.

https://doi.org/10.1093/bja/81.4.507

15. Li G, Wang H, Qi X, Huang X, Li Y. Intrathecal dexmedetomidine improves epidural labor analgesia effects: a randomized controlled trial. nt. J Med Res 2021; 49(4): 51-59.

https://doi.org/10.1177/0300060521999534

16. Ye W, Hu Z, Jin X. Retrobulbar dexmedetomidine decreases the MLAC of ropivacaine in vitreoretinal surgery in children. Eur J Ophthalmol 2015; 25(4): 352-356.

https://doi.org/10.5301/ejo.5000549

17. Mowar A, Singh V, Pahade A, Karki G. Effect of three different doses of intrathecal dexmedetomidine on subarachnoid block: a prospective randomized double-blind trial. Apicare 2022; 26(1): 8-13. https://doi.org/10.35975/apic.v26i1.1759

18. Nanji JA, Carvalho B. Pain management during labor and vaginal birth. Best Pract Res Clin Obstet Gynaecol 2020; 67: 100-112. https://doi.org/10.1016/j.bpobgyn.2020.03.002

19. Nasseri K, Ghadami N, Nouri B. Effects of intrathecal dexmedetomidine on shivering after spinal anesthesia for cesarean section: a double-blind randomized clinical trial. Drug Des Devel Ther 2017; 11: 1107-1113.

https://doi.org/10.2147/DDDT.S131866